The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 323-326 , March 2010

Cardiac hormones ANF and BNP modulate proliferation in the unidirectional mixed lymphocyte reaction

References 

  1. Masters RG, Davies RA, Keon WJ, et al. Neuroendocrine response to cardiac transplantation. Can J Cardiol. 1993;9:609–617
  2. Masters RG, Davies RA, Veinot JP, et al. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation. 1999;100:287–291
  3. Ogawa T, Veinot JP, Davies RA, et al. Neuroendocrine profiling of humans receiving cardiac allografts. J Heart Lung Transplant. 2005;24:1046–1054
  4. de Bold AJ. Determinants of brain natriuretic peptide gene expression and secretion in acute cardiac allograft rejection. Curr Opin Cardiol. 2007;22:146–150
  5. Ogawa T, Veinot JP, Kuroski de Bold ML, et al. Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis. Am J Physiol Heart Circ Physiol. 2008;294:H2596–H2603
  6. Meirovich YF, Veinot JP, de Bold ML, et al. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant. 2008;27:31–37
  7. Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol. 2004;36:505–513
  8. Hervas I, Arnau MA, Almenar L, et al. Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures. Lab Invest. 2004;84:138–141
  9. Wu AH, Johnson ML, Aaronson KD, et al. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant. 2005;24:52–57
  10. Wang Y, Zhou Y, Meng L, et al. Inflammatory mediators in Chinese patients with congestive heart failure. J Clin Pharmacol. 2009;49:591–599
  11. McGrath MF, de Bold ML, de Bold AJ. The endocrine function of the heart. Trends Endocrinol Metab. 2005;16:469–477
  12. Vollmar AM. The role of atrial natriuretic peptide in the immune system. Peptides. 2005;26:1086–1094
  13. Chiurchiu V, Izzi V, D'Aquilio F, et al. Brain natriuretic peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages. Regul Peptides. 2008;148:26–32
  14. Suganami T, Mukoyama M, Sugawara A, et al. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J Am Soc Nephrol. 2001;12:2652–2663
  15. Shaw SM, Fildes JE, Puchalka CM, et al. BNP directly immunoregulates the innate immune system of cardiac transplant recipients in vitro. Transplant Immunol. 2009;20:199–202
  16. Rubattu S, Sciarretta S, Valenti V, et al. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens. 2008;21:733–741
  17. McGrath MF, de Bold AJ. Determinants of natriuretic peptide gene expression. Peptides. 2005;26:933–943
  18. Kiemer AK, Vollmar A. The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages. Ann Rheum Dis. 2001;60(suppl 3):68–70iii
  19. Mohapatra SS. Role of natriuretic peptide signaling in modulating asthma and inflammation. Can J Physiol Pharmacol. 2007;85:754–759
  20. Ma KK, Banas K, de Bold AJ. Determinants of inducible brain natriuretic peptide promoter activity. Regul Peptides. 2005;128:169–176

PII: S1053-2498(09)00583-X

doi: 10.1016/j.healun.2009.07.008

The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 323-326 , March 2010

Article Tools

* Image Usage & Resolution